| Literature DB >> 19447771 |
Andrew McLean-Tooke1, Catherine Aldridge, Sheila Waugh, Gavin P Spickett, Lesley Kay.
Abstract
Low-dose MTX administered weekly remains a mainstay in the therapy of RA. There is a belief amongst rheumatologists that RA patients taking MTX have both an increased risk and severity of infection. Here we review the published data on the risks of infection associated with the use of MTX in patients with RA and make some recommendations for managing MTX in patients with infection.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19447771 DOI： 10.1093/rheumatology/kep101
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580